From Acera Surgical and Telos Medical’s partnership to Xtant Medical’s 510(k) clearance, here are seven medtech stories we missed this week but thought were still worth a mention.
1. Acera Surgical partners with Telos Medical for Restrata wound matrix trial
Telos Partners announced in a Sept. 14 press release that Acera Surgical has chosen Telos to lead its Restrata wound matrix study. The study will surgery the clinical outcomes of Restrata treatments for diabetic foot ulcers and test for effectiveness and safety. Restrata is a fully synthetic wound matrix that is FDA-cleared for wound indications.
2. Pinnacle Sciences launches mask-mounted CPAP machine
Pinnacle Sciences has recently developed a portable, battery-operated ventilating CPAP mask for sleep apnea, according to a Sept. 14 press release. The device has several modes of therapy and fits directly on the mask to reduce the amount of dead space. Lower pressures are used in this devices meaning patient comfort will be significantly increased, according to the company. The device is also able to be used with a tube, mounted on clothing or put in a pocket. It is expected to cost around $330. Variations of the device will include full ventilation, cough assistance and high-frequency modes.
3. Plusoptix launches pediatric vision screener
Plusoptix announced in a Sept. 14 press release that it has released its new plusoptiX S16 series vision screening device for use in pediatric clinics. The plusoptiX S16 is designed to help pediatricians easily and reliably detect eye disorders early on in children. They can get reliable measurement values for refraction, pupil diameter, pupil disease and symmetry of corneal reflexes to help detect conditions use as amblyopia (lazy eye) including hyperopia (farsightedness), myopia (nearsightedness), astigmatism (blurred vision), anisometropia (unequal refractive power), anisocoria (unequal pupil size) and strabismus (eye misalignment). The device is stationary and can be connected to a network server to exchange data.